» Articles » PMID: 31398292

The Annexin A1/FPR2 Signaling Axis Expands Alveolar Macrophages, Limits Viral Replication, and Attenuates Pathogenesis in the Murine Influenza A Virus Infection Model

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2019 Aug 10
PMID 31398292
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Pattern recognition receptors (PRRs) are key elements in the innate immune response. Formyl peptide receptor (FPR) 2 is a PRR that, in addition to proinflammatory, pathogen-derived compounds, also recognizes the anti-inflammatory endogenous ligand annexin A1 (AnxA1). Because the contribution of this signaling axis in viral infections is undefined, we investigated AnxA1-mediated FPR2 activation on influenza A virus (IAV) infection in the murine model. AnxA1-treated mice displayed significantly attenuated pathology upon a subsequent IAV infection with significantly improved survival, impaired viral replication in the respiratory tract, and less severe lung damage. The AnxA1-mediated protection against IAV infection was not caused by priming of the type I IFN response but was associated with an increase in the number of alveolar macrophages (AMs) and enhanced pulmonary expression of the AM-regulating cytokine granulocyte-M-CSF (GM-CSF). Both AnxA1-mediated increase in AM levels and GM-CSF production were abrogated when mouse (m)FPR2 signaling was antagonized but remained up-regulated in mice genetically deleted for mFPR1, an mFPR2 isoform also serving as AnxA1 receptor. Our results indicate a novel protective function of the AnxA1-FPR2 signaling axis in IAV pathology GM-CSF-associated maintenance of AMs, expanding knowledge on the potential use of proresolving mediators in host defense against pathogens.-Schloer, S., Hübel, N., Masemann, D., Pajonczyk, D., Brunotte, L., Ehrhardt, C., Brandenburg, L.-O., Ludwig, S., Gerke, V., Rescher, U. The annexin A1/FPR2 signaling axis expands alveolar macrophages, limits viral replication, and attenuates pathogenesis in the murine influenza A virus infection model.

Citing Articles

Treatment with lipoxin A improves influenza A infection outcome, induces macrophage reprogramming, anti-inflammatory and pro-resolutive responses.

Rago F, Melo E, Miller L, Duray A, Felix F, Vago J Inflamm Res. 2024; 73(11):1903-1918.

PMID: 39214890 DOI: 10.1007/s00011-024-01939-9.


Treatment with lipoxin A 4 improves influenza A infection outcome through macrophage reprogramming, anti-inflammatory and pro-resolutive responses.

Rago F, Melo E, Miller L, Duray A, Felix F, Vago J Res Sq. 2024; .

PMID: 38947034 PMC: 11213203. DOI: 10.21203/rs.3.rs-4491036/v1.


Annexins-a family of proteins with distinctive tastes for cell signaling and membrane dynamics.

Gerke V, Gavins F, Geisow M, Grewal T, Jaiswal J, Nylandsted J Nat Commun. 2024; 15(1):1574.

PMID: 38383560 PMC: 10882027. DOI: 10.1038/s41467-024-45954-0.


The Multifaceted Role of Annexin A1 in Viral Infections.

Resende F, Araujo S, Tavares L, Teixeira M, Costa V Cells. 2023; 12(8).

PMID: 37190040 PMC: 10137178. DOI: 10.3390/cells12081131.


FMDV 3A Antagonizes the Effect of ANXA1 to Positively Modulate Viral Replication.

Ma X, Zhang K, Luo Z, Nian X, Choudhury S, Zhu Z J Virol. 2022; 96(12):e0031722.

PMID: 35604142 PMC: 9215249. DOI: 10.1128/jvi.00317-22.


References
1.
Yona S, Kim K, Wolf Y, Mildner A, Varol D, Breker M . Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity. 2013; 38(1):79-91. PMC: 3908543. DOI: 10.1016/j.immuni.2012.12.001. View

2.
Manicassamy B, Medina R, Hai R, Tsibane T, Stertz S, Nistal-Villan E . Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 2010; 6(1):e1000745. PMC: 2813279. DOI: 10.1371/journal.ppat.1000745. View

3.
Ghoneim H, Thomas P, McCullers J . Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J Immunol. 2013; 191(3):1250-9. PMC: 4907362. DOI: 10.4049/jimmunol.1300014. View

4.
Zhang H, Luo J, Alcorn J, Chen K, Fan S, Pilewski J . AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality. J Immunol. 2017; 198(11):4383-4393. PMC: 5439025. DOI: 10.4049/jimmunol.1600714. View

5.
Happle C, Lachmann N, Skuljec J, Wetzke M, Ackermann M, Brennig S . Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis. Sci Transl Med. 2014; 6(250):250ra113. DOI: 10.1126/scitranslmed.3009750. View